Gilead Sciences
Ad
related to: Ligand PharmaceuticalsLigand design to ensure an efficient PROTAC molecule. Advanced ligand design platform. Aslo provide rapid affinity identification service of ligand candidates for the proteins.
Search results
Ligand is a healthcare investing company that provides technology and financing solutions to advance medicines. It owns royalties on more than 100 partnered programs and licenses its Captisol® platform to biopharmaceutical partners.
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to ...
Ligand invests in the clinical development and commercialization of high-value programs that can improve and extend lives. It also licenses its Captisol® technology platform to biopharmaceutical partners and generates royalties from its diversified portfolio of royalty assets.
Find the latest Ligand Pharmaceuticals Incorporated (LGND) stock quote, history, news and other vital information to help you with your stock trading and investing.
Jul 8, 2024 · Ligand is a biopharmaceutical company that invests in and licenses high-value programs for various diseases. It also owns the Captisol® technology platform and generates royalty revenue from its portfolio of treatments.
Ligand is a high-growth company with economic rights to some of the world's most important medicines. | Ligand is a biopharmaceutical company focused on developing or acquiring technologies...
Get the latest Ligand Pharmaceuticals Inc (LGND) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
